glp 1 photo GLP-1 Agonists - What is it? The 3 Most Common GLP-1

Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists - mechanisms, clinical evidence, and therapeutic perspectives Hepatoma Res

Zhu Z, Luo H, Lu W, Luan H, Wu Y, Luo J, Wang Y, Pi J, Lim CY, Wang H

02MeAgain works wherever your prescription comes from It is easy to assume the medication question decides this comparison

Large-scale epidemiological studies have confirmed that metformin users have a significantly lower risk of developing various malignancies, including bladder, lung, prostate, pancreatic, head and neck, esophageal, liver, and colorectal cancers, compared to non-users [10]

But what I am finding the most difficult is how to help people understand why I think they have lost too much weight, and why in some cases I insist on stopping or significantly lowering the dose of their GLP-1 treatment